• World Neurosurg · Nov 2024

    Fractionated radiotherapy with stereotactic radiosurgery boost controls gross disease in grade 2 meningioma.

    • Rebecca L Calafiore, Corbin A Helis, Paul Marcet, Eleanor Smith, Benjamin Ramsey, Heather Pacholke, Carol A Kittel, Marc Benayoun, James D Ververs, Christina K Cramer, Adrian W Laxton, Stephen B Tatter, Michael D Chan, and Jaclyn J White.
    • Department of Neurological Surgery, Wake Forest School of Medicine, Winston-Salem, NC, USA. Electronic address: rcalafio@wakehealth.edu.
    • World Neurosurg. 2024 Nov 21.

    Background And ObjectivesOpportunity exists for improved local control rates of grade 2 meningiomas that recur despite maximal surgical resection and adjuvant fractionated radiotherapy. We describe a dose escalation strategy of increasing the total tumor radiation dose by adding a stereotactic radiosurgery (SRS) boost targeting gross disease to fractionated radiotherapy.MethodsA single institution retrospective cohort of patients from 2009-2023 with grade 2 meningioma treated with surgical resection, fractionated radiotherapy, and SRS boost were evaluated for baseline characteristics, local disease control, and adverse events (AE).ResultsFourteen meningioma patients were included. Ten patients (71.4%) underwent radiosurgery at initial diagnosis, while 4 patients (28.6%) were treated for recurrent disease. The median fractionated dose was 54 Gy, while the median dose for SRS was 7.5 Gy. Among the 13 patients with follow-up available, median follow-up was 34 months. Three patients (23%) had treatment failures, however, none occurred within the SRS volume and two thirds occurred in patients treated for recurrent disease. 18-month PFS was 92.3%, while 18-month overall survival was 100%. Most patients experienced no or mild AEs, however, 3 patients (23%) experienced a high-grade (CTCAE v5.0 grade ≥ 3) AE including radiation necrosis, seizures and cognitive decline.ConclusionsWe found 100% in-field local control at three years from an SRS boost to fractionated radiotherapy targeting gross disease with an acceptable toxicity profile, suggesting this may be an effective and improved adjuvant treatment strategy in patients with grade 2 meningioma.Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.

      Pubmed     Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…